A few years ago, Buch et al. investigated synovial biopsies from established RA and could demonstrate a decrease of number of B cells after 16 weeks of therapy and reduced mRNA levels for IFN-γ [26]. The gene discussed is IFNG; the disease is rheumatoid arthritis.